Keeping Track: Biosimilars, Novel Approvals, And Ebola

 
• By Michael Cipriano

The latest drug development news and highlights from our US FDA Performance Tracker include a Neulasta biosimilar approval for Sandoz, novel approvals for Celgene's Reblozyl and Giskit B.V.'s ExEm Foam, and a submission for Regeneron's Ebola candidate.

Keeping Track Feature image

More from US FDA Performance Tracker

More from Regulatory Trackers